A61K9/1623 - page 5 - CPC Classification Index

#1201

20120219589

2012-08-30

Formulation of drugs and vaccines in the form of percutaneous injectable needles

#1202

20120213846

2012-08-23

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#1203

20120209027

2012-08-16

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

#1204

20120208886

2012-08-16

Moisture Resistant Container Systems for Rapidly Bioavailable Dosage Forms

#1205

20120207841

2012-08-16

Formulations of 6-mercaptopurine

#1206

20120202736

2012-08-09

SPRAY-DRIED COLLECTIN COMPOSITIONS AND PROCESS FOR PREPARING THE SAME

#1207

20120202694

2012-08-09

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#1208

20120201889

2012-08-09

MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE

#1209

20120201847

2012-08-09

Vaccine formulations and uses thereof

#1210

20120196940

2012-08-02

PHARMACEUTICAL FORMULATIONS

#1211

20120195980

2012-08-02

Method, composition and package for bowel cleansing

#1212

20120190657

2012-07-26

Biphenyl compounds useful as muscarinic receptor antagonists

#1213

20120189693

2012-07-26

ORAL DOSAGE FORMS

#1214

20120184627

2012-07-19

Pharmaceutical composition

#1215

20120178687

2012-07-12

Osmotic delivery comprising an insulinotropic peptide and uses thereof

#1216

20120177705

2012-07-12

COMPOSITION 064

#1217

20120172355

2012-07-05

Aminodihydrothiazine derivatives substituted with a cyclic group

#1218

20120171297

2012-07-05

Threo-DOPS controlled release formulation

#1219

20120171293

2012-07-05

Granulated material mixture comprising two different granulated materials for artificial callus distraction

#1220

20120171262

2012-07-05

PHARMACEUTICAL FORMULATIONS

#1221

20120164228

2012-06-28

Pharmaceutical formulations to prevent the misuse of medicinal drugs

#1222

20120164209

2012-06-28

Abuse resistant oral opioid formulations

#1223

20120160944

2012-06-28

METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICRO PARTICLE POWDERS

#1224

20120157459

2012-06-21

3-hydroxy-5-arylisothiazole derivative

#1225

20120156277

2012-06-21

Abuse resistant forms of immediate release oxycodone, method of use and method of making

#1226

20120149752

2012-06-14

KIT FOR BALANCING NEUROTRANSMITTER LEVELS

#1227

20120148661

2012-06-14

HIGH BIOAVAILABILITY ORAL PICOPLATIN ANTI-CANCER THERAPY

#1228

20120148635

2012-06-14

Gallium formulation for the treatment and prevention of infectious diseases

#1229

20120148634

2012-06-14

NOVEL FORMULATION OF NAPROXEN

#1230

20120138056

2012-06-07

DRY POWDER COMPOSITION COMPRISING CO-JET MILLED PARTICLES FOR PULMONARY INHALATION

#1231

20120135969

2012-05-31

NOVEL POWDERED CRYSTALLINE MEDICINES FOR INHALATION

#1232

20120135083

2012-05-31

Dried product and a process for manufacturing the product

#1233

20120128729

2012-05-24

Gallium formulation for the treatment and prevention of infectious diseases

#1234

20120122782

2012-05-17

COMPLEXATION OF METAL IONS WITH POLYPEPTIDES

#1235

20120121663

2012-05-17

Treatment using dantrolene

#1236

20120121662

2012-05-17

Treatment using dantrolene

#1237

20120114754

2012-05-10

RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORM

#1238

20120114752

2012-05-10

Stable tablet containing 4,5-epoxymorphinan derivative

#1239

20120114748

2012-05-10

Tanaproget compositions containing ethinyl estradiol

#1240

20120108464

2012-05-03

TEST SYSTEMS, METHODS AND USES INVOLVING AS160 PROTEIN

#1241

20120107241

2012-05-03

Particles for Inhalation Having Sustained Release Properties

#1242

20120101077

2012-04-26

AGGLOMERATE FORMULATIONS USEFUL IN DRY POWDER INHALERS

#1243

20120093887

2012-04-19

AMORPHOUS VARENICLINE TARTRATE CO-PRECIPITATES

#1244

20120093886

2012-04-19

Pharmaceutical compositions and related methods of delivery

#1245

20120082718

2012-04-05

Morphine Formulations

#1246

20120082656

2012-04-05

COMPOSITION COMPRISING THE PURIFIED EXTRACT OF BEE VENOM FOR PREVENTING AND TREATING DEGENERATIVE BRAIN DISEASE

#1247

20120071543

2012-03-22

FORMULATIONS OF DILUTED GENETIC MATERIAL AND METHODS FOR MAKING SAME

#1248

20120070492

2012-03-22

Rhein or diacerein compositions

#1249

20120070477

2012-03-22

Dry powder fibrin sealant

#1250

20120064160

2012-03-15

Fibrate-statin Combinations with Reduced Fed-fasted Effects

#1251

20120064154

2012-03-15

SOLID DRUG FOR ORAL USE

#1252

20120063996

2012-03-15

NOVEL NIMESULIDE COMPOSITIONS

#1253

20120053238

2012-03-01

SOLID RETIGABINE IN NON-CRYSTALLINE FORM

#1254

20120046330

2012-02-23

PHARMACEUTICAL COMPOSITIONS OF (R)-1-(2,2-DIFLUOROBENZO[D] [1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE AND ADMINISTRATION THEREOF

#1255

20120046315

2012-02-23

INTERMEDIATE AND ORAL ADMINISTRATIVE FORMATS CONTAINING LENALIDOMIDE

#1256

20120045563

2012-02-23

Resveratrol compositions

#1257

20120038073

2012-02-16

Spray drying methods and related compositions

#1258

20120035177

2012-02-09

TABLET FORMULATION FOR P38 INHIBITOR AND METHOD

#1259

20120029070

2012-02-02

Burdock fruit extract containing arctigenin at high content and process for producing same

#1260

20120028964

2012-02-02

Pharmaceutical combination

#1261

20120027855

2012-02-02

PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY

#1262

20120027852

2012-02-02

PHARMACEUTICAL COMPOSITION CONTAINING A "LIMUS" FAMILY IMMUNOSUPPRESSIVE MACROLIDE

#1263

20120027849

2012-02-02

Stable pharmaceutical composition for atherosclerosis

#1264

20120022249

2012-01-26

Aminodihydrothiazine derivatives

#1265

20120021021

2012-01-26

Method for preparing pharmaceutical compositions comprising fine particles of active substance

#1266

20120016116

2012-01-19

Aminodihydrothiazine derivatives

#1267

20120015921

2012-01-19

Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

#1268

20120010216

2012-01-12

Pharmaceutical compositions containing vanoxerine

#1269

20120009248

2012-01-12

Preservation of bioactive materials by spray drying

#1270

20120009229

2012-01-12

Pharmaceutical compositions and related methods of delivery

#1271

20120009225

2012-01-12

Stable Solid Formulation of Therapeutic Polypeptides Suitable for Oral Administration

#1272

20110319625

2011-12-29

Biphenyl compounds useful as muscarinic receptor antagonists

#1273

20110312885

2011-12-22

Controlled release system and manufacturing method thereof

#1274

20110311618

2011-12-22

INHALABLE PARTICLES COMPRISING TIOTROPIUM

#1275

20110306539

2011-12-15

Process for making particles for delivery of drug nanoparticles

#1276

20110305762

2011-12-15

Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-quinazolinamine

#1277

20110301234

2011-12-08

FORMULATIONS OF LADOSTIGIL TARTRATE

#1278

20110300192

2011-12-08

MAGNESIUM OXIDE GRANULES

#1279

20110294904

2011-12-01

Dry Granulation Binders, Products, and Use Thereof

#1280

20110293729

2011-12-01

Composition based on gamma-hydroxybutyric acid

#1281

20110293717

2011-12-01

COMPACTED MOXIFLOXACIN

#1282

20110288079

2011-11-24

Tannate compositions, methods of making and methods of use

#1283

20110287256

2011-11-24

PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION

#1284

20110287097

2011-11-24

PHARMACEUTICAL COMPOSITIONS COMPRISING ROPINIROLE

#1285

20110284412

2011-11-24

PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION

#1286

20110281929

2011-11-17

Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives

#1287

20110280967

2011-11-17

Disintegrable formulations of lanthanum carbonate

#1288

20110280956

2011-11-17

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

#1289

20110263632

2011-10-27

Solid dispersions comprising tacrolimus

#1290

20110262384

2011-10-27

Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation

#1291

20110257095

2011-10-20

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#1292

20110256220

2011-10-20

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

#1293

20110256190

2011-10-20

Modified release compositions comprising tacrolimus

#1294

20110251232

2011-10-13

Modified release compositions comprising tacrolimus

#1295

20110251231

2011-10-13

Modified release compositions comprising tacrolimus

#1296

20110250277

2011-10-13

Modified release compositions comprising tacrolimus

#1297

20110250271

2011-10-13

SPACED DRUG DELIVERY SYSTEM

#1298

20110244042

2011-10-06

Stabilized formulations of CNS compounds

#1299

20110243996

2011-10-06

Spray freeze dry of compositions for intranasal administration

#1300

20110243988

2011-10-06

Methods and Compositions for Stabilization of a Virus Vaccine

#1301

20110237628

2011-09-29

Cyclopentyl- and cycloheptylpyrazoles

#1302

20110237616

2011-09-29

PHEHYLEPHRINE FORMULATIONS WITH IMPROVEDS STABILITY

#1303

20110237609

2011-09-29

ANTIFOLATE COMPOSITIONS

#1304

20110236369

2011-09-29

Dosage forms that facilitate rapid activation of barley protease zymogen

#1305

20110217340

2011-09-08

NANODISPERSE COMPOSITIONS

#1306

20110213004

2011-09-01

Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor

#1307

20110212138

2011-09-01

Sustained release formulations using non-aqueous carriers

#1308

20110208168

2011-08-25

Particle formulations for use in pharmaceutical compositions

#1309

20110206744

2011-08-25

MODAFINIL FORMULATIONS

#1310

20110201685

2011-08-18

Compositions

#1311

20110195917

2011-08-11

Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate

#1312

20110195136

2011-08-11

Drop pill for treating coronary heart disease and preparation thereof

#1313

20110195097

2011-08-11

Composition and dosage form comprising a particle formulation and suspending vehicle

#1314

20110190356

2011-08-04

Compositions and Methods of Using (R)- Pramipexole

#1315

20110190279

2011-08-04

Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity

#1316

20110189311

2011-08-04

Highly Absorbable Drug Composition and Method of Producing the Same

#1317

20110189249

2011-08-04

Low pH retinoid topical compositions

#1318

20110184007

2011-07-28

Pharmaceutical compositions configured to deter dosage form splitting

#1319

20110182993

2011-07-28

Film-form preparation

#1320

20110165253

2011-07-07

Nicotine-containing granulate

#1321

20110159090

2011-06-30

Abuse resistant drugs, method of use and method of making

#1322

20110159089

2011-06-30

Abuse resistant forms of extended release morphine, method of use and method of making

#1323

20110159082

2011-06-30

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

#1324

20110159049

2011-06-30

PHARMACEUTICAL COMPOSITION

#1325

20110151008

2011-06-23

Pulmonary delivery for levodopa

#1326

20110150991

2011-06-23

Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making

#1327

20110150990

2011-06-23

Abuse resistant forms of extended release hydrocodone, method of use and method of making

#1328

20110150971

2011-06-23

Abuse resistant forms of extended release oxymorphone, method of use and method of making

#1329

20110150970

2011-06-23

Abuse resistant forms of extended release oxycodone, method of use, and method of making

#1330

20110150969

2011-06-23

Abuse resistant forms of extended release hydromorphone, method of use and method of making

#1331

20110150940

2011-06-23

DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION

#1332

20110150927

2011-06-23

Stabilisation of Viral Microparticles

#1333

20110142930

2011-06-16

Pharmaceutical Compositions of Atorvastatin

#1334

20110142929

2011-06-16

Solid pharmaceutical formulations comprising BIBW 2992

#1335

20110142914

2011-06-16

INHALABLE COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY

#1336

20110136921

2011-06-09

SUSTAINED RELEASE COMPOSITION

#1337

20110136883

2011-06-09

GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS

#1338

20110135927

2011-06-09

Excipient for compressed tablets comprising novel spherical mannitol

#1339

20110135738

2011-06-09

SINGLE DOSAGE PHARMACEUTICAL FORMULATION COMPRISING EPROSARTAN MESYLATE

#1340

20110130422

2011-06-02

Biphenyl compounds useful as muscarinic receptor antagonists

#1341

20110129533

2011-06-02

Porous drug matrices and methods of manufacture thereof

#1342

20110129455

2011-06-02

INHIBITORS OF AKT ACTIVITY

#1343

20110123631

2011-05-26

Oral compositions of clindamycin

#1344

20110118288

2011-05-19

Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof

#1345

20110112160

2011-05-12

TABLET COMPRISING EPROSARTAN MESYLATE

#1346

20110111037

2011-05-12

Orodispersible mannitol

#1347

20110111022

2011-05-12

PHARMACEUTICAL FORMULATION

#1348

20110108646

2011-05-12

Process and apparatus for continuous wet granulation of powder material

#1349

20110105613

2011-05-05

Moisture resistant container systems for rapidly bioavailable dosage forms

#1350

20110097409

2011-04-28

PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION

#1351

20110092423

2011-04-21

INHIBITORS OF Akt ACTIVITY

#1352

20110091546

2011-04-21

Composition for rapid disintegrating tablet in oral cavity

#1353

20110086019

2011-04-14

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR

#1354

20110076325

2011-03-31

Abuse resistant drugs, method of use and method of making

#1355

20110059903

2011-03-10

Formulations comprising linaclotide

#1356

20110052707

2011-03-03

COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3

#1357

20110046099

2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

#1358

20110046095

2011-02-24

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

#1359

20110045079

2011-02-24

DRY POWDERS OF CELLULAR MATERIAL

#1360

20110039800

2011-02-17

Prolonged release bioadhesive therapeutic systems

#1361

20110028526

2011-02-03

VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS

#1362

20110027372

2011-02-03

MULTIPARTICULATES COMPRISING LOW-SOLUBILITY DRUGS AND CARRIERS THAT RESULT IN RAPID DRUG RELEASE

#1363

20110015163

2011-01-20

Crystalline freebase forms of a biphenyl compound

#1364

20110009362

2011-01-13

SOLUBILITY-ENHANCED FORMS OF APREPITANT AND PHARMACEUTICAL COMPOSITIONS THEREOF

#1365

20110008453

2011-01-13

Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof

#1366

20110005523

2011-01-13

Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation

#1367

20110003004

2011-01-06

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

#1368

20110002985

2011-01-06

Abuse resistant oral opioid formulations

#1369

20100331356

2010-12-30

Self-microemulsifying drug delivery systems

#1370

20100330191

2010-12-30

Diaminooxidase-containing pharmaceutical compositions

#1371

20100323006

2010-12-23

Pharmaceutical solid preparation comprising benzazepines and production method thereof

#1372

20100317575

2010-12-16

PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE

#1373

20100316725

2010-12-16

REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS

#1374

20100316724

2010-12-16

COMPOSITION

#1375

20100310668

2010-12-09

PHARMACEUTICAL COMPOSITIONS COMPRISING N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE

#1376

20100310660

2010-12-09

DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY

#1377

20100310607

2010-12-09

PHARMACEUTICAL FORMULATIONS

#1378

20100303907

2010-12-02

Standardized plant extract, process for obtaining the same and uses thereof

#1379

20100285142

2010-11-11

Method of making particles for use in a pharmaceutical composition

#1380

20100280059

2010-11-04

COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS

#1381

20100278924

2010-11-04

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

#1382

20100273982

2010-10-28

PROCESS FOR PRODUCTION OF BIVALIRUDIN

#1383

20100273886

2010-10-28

Formulations and methods for lyophilization and lyophilates provided thereby

#1384

20100273873

2010-10-28

DIRECT COMPRESSIBLE DEXTROSE

#1385

20100269819

2010-10-28

Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions

#1386

20100267960

2010-10-21

PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS

#1387

20100267785

2010-10-21

Candesartan cilexetil

#1388

20100266706

2010-10-21

ORAL PARTICULATE ANTITUMOR PREPARATION

#1389

20100260854

2010-10-14

GRANULATE FOR THE FORMULATION OF ORODISPERSIBLE TABLETS

#1390

20100260844

2010-10-14

Oral pharmaceutical dosage forms

#1391

20100260811

2010-10-14

Compositions of fat-soluble substances

#1392

20100260763

2010-10-14

Polypeptides, antibody variable domains and antagonists methods for

#1393

20100256194

2010-10-07

PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME

#1394

20100256102

2010-10-07

C-19 steroids for cosmetic and further uses

#1395

20100254995

2010-10-07

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS

#1396

20100254972

2010-10-07

METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES

#1397

20100249421

2010-09-30

Biphenyl compounds useful as muscarinic receptor antagonists

#1398

20100247737

2010-09-30

METHOD FOR PRODUCING GRANULATED PREPARATION

#1399

20100247665

2010-09-30

Spherical Particle and Method for Producing the Same

#1400

20100247661

2010-09-30

Method of drug formulation of compositions comprising crystalline microparticle surfaces

#1401

20100247649

2010-09-30

PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE

#1402

20100247609

2010-09-30

Pharmaceutical compositions

#1403

20100240711

2010-09-23

SOLID PREPARATION COMPRISING NPYY5 RECEPTOR ANTAGONIST

#1404

20100239681

2010-09-23

Controlled Release Particulates Containing Water-Insoluble Drug

#1405

20100239662

2010-09-23

Misuse preventative, controlled release formulation

#1406

20100234430

2010-09-16

METHODS AND PHARMACEUTICAL FORMULATIONS FOR PROTECTING PHARMACEUTICAL COMPOUNDS FROM ACIDIC ENVIRONMENTS

#1407

20100233276

2010-09-16

COMPOSITIONS IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND OF A TWO-COMPONENTS EXCIPIENT, AND PROCESS FOR THEIR PREPARATION

#1408

20100233265

2010-09-16

Matrix-type pharmaceutical solid preparation

#1409

20100226994

2010-09-09

GRANULE, TABLET AND METHODS FOR PRODUCING THE SAME

#1410

20100226990

2010-09-09

Method of Producing Porous Microparticles

#1411

20100226944

2010-09-09

PROCESS FOR THE PREPARATION OF CONTROLLED-RELEASE SOLID FORMULATIONS CONTAINING OXCARBAZEPINE, AND FORMULATIONS OBTAINABLE BY SAID PROCESS

#1412

20100222427

2010-09-02

Pharmaceutical composition comprising oseltamivir phosphate

#1413

20100221333

2010-09-02

Pellets Comprising a Core With a Water-Soluble Carrier

#1414

20100210605

2010-08-19

Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar

#1415

20100204330

2010-08-12

Diclofenac formulations and methods of use

#1416

20100204211

2010-08-12

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#1417

20100196468

2010-08-05

Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt

#1418

20100183721

2010-07-22

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

#1419

20100178648

2010-07-15

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

#1420

20100178342

2010-07-15

Solid Pharmaceutical Preparation

#1421

20100178306

2010-07-15

Pharmaceutical formulation for the production of rapidly disintegrating tablets

#1422

20100168663

2010-07-01

DEVICE FOR THE ORAL ADMINISTRATION OF ACTIVE INGREDIENTS

#1423

20100160400

2010-06-24

Treatment using dantrolene

#1424

20100160290

2010-06-24

Pharmaceutical composition for treating Alzheimer's disease

#1425

20100152173

2010-06-17

Tablet Having Improved Stability With At Least Two Actives

#1426

20100152111

2010-06-17

Polymer-based sustained release device

#1427

20100152097

2010-06-17

Polymer-based sustained release device

#1428

20100151012

2010-06-17

STABILISED PHARMACEUTICAL COMPOSITION CONTAINING PREGABALINE

#1429

20100150900

2010-06-17

Dry powder fibrin sealant

#1430

20100143461

2010-06-10

PALONOSETRON FORMULATION

#1431

20100143331

2010-06-10

METHOD FOR MIXING POWDERS

#1432

20100137348

2010-06-03

Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

#1433

20100137213

2010-06-03

Formulations of single domain antigen binding molecules

#1434

20100129444

2010-05-27

Novel Pharmaceutical Formulations of Modafinil

#1435

20100129441

2010-05-27

Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa

#1436

20100125103

2010-05-20

COMPOSITION FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME CONTAINING OBOVATOL AND ITS SYNTHESIZED DERIVATIVES

#1437

20100124557

2010-05-20

Vaccine formulations and uses thereof

#1438

20100124536

2010-05-20

Hemophilia Treatment by Inhalation of Coagulation Factors

#1439

20100120868

2010-05-13

Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate

#1440

20100120848

2010-05-13

STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM

#1441

20100119621

2010-05-13

Process for preparing oral calcium compositions

#1442

20100114014

2010-05-06

PHARMACEUTICAL COMPOSITIONS STABILISED IN GLASSY PARTICLES

#1443

20100112070

2010-05-06

Composition and dosage form comprising a particle formulation and suspending vehicle

#1444

20100112049

2010-05-06

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

#1445

20100105648

2010-04-29

Solid pharmaceutical composition comprising (R)-(−)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman

#1446

20100105627

2010-04-29

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#1447

20100093875

2010-04-15

GRANULAR PREPARATION PREVENTED FROM CAKING

#1448

20100092566

2010-04-15

Highly concentrated drug particles, formulations, suspensions and uses thereof

#1449

20100092453

2010-04-15

Method of producing porous microparticles

#1450

20100087463

2010-04-08

Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate

#1451

20100087412

2010-04-08

Micronized Eplerenone Compositions

#1452

20100086586

2010-04-08

Pharmaceutical Composition

#1453

20100080849

2010-04-01

PELLETS CONTAINING A PHARMACEUTICAL SUBSTANCE, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME

#1454

20100075957

2010-03-25

Aminodihydrothiazine derivatives substituted with a cyclic group

#1455

20100064796

2010-03-18

Method for aligning a component into a wind direction and sensor for determining misalignment of a component relative to a wind direction

#1456

20100055193

2010-03-04

Stable powder formulation containing an anticholinergic agent

#1457

20100048489

2010-02-25

Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration

#1458

20100041688

2010-02-18

Revaprazan-containing solid dispersion and process for the preparation thereof

#1459

20100035800

2010-02-11

NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF

#1460

20100034956

2010-02-11

Highly Water Dispersible Powder and Production Method Thereof

#1461

20100034910

2010-02-11

Spray drying process control of drying kinetics

#1462

20100034894

2010-02-11

Use of Sucralose as a Granulating Agent

#1463

20100034888

2010-02-11

GRANULATE CONTAINING A PHARMACEUTICALLY ACTIVE SUBSTANCE AND METHOD FOR ITS MANUFACTURE

#1464

20100034887

2010-02-11

Bursting Pellets

#1465

20100029916

2010-02-04

PROCESS FOR PRODUCTION OF BIVALIRUDIN

#1466

20100028472

2010-02-04

Herbal composition and process for its preparation

#1467

20100028422

2010-02-04

Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease

#1468

20100016378

2010-01-21

Method of preventing dihydropyridine compound from degradation

#1469

20100015225

2010-01-21

SOLID DISPERSION OF A NEUROKININ ANTAGONIST

#1470

20100010028

2010-01-14

Use of polyols to obtain stable polymorphous forms of rifaximin

#1471

20100008984

2010-01-14

Solid dispersions comprising tacrolimus

#1472

20100008956

2010-01-14

COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS

#1473

20100004295

2010-01-07

Hydrazine amide derivative

#1474

20090326078

2009-12-31

PROCESS FOR PREPARING A SOLID DOSAGE FORM

#1475

20090326025

2009-12-31

Pharmaceutical composition

#1476

20090324794

2009-12-31

Granulated sorbitol and process for its preparation

#1477

20090317481

2009-12-24

MODAFINIL FORMULATIONS

#1478

20090311317

2009-12-17

MODIFIED RELEASE TOLTERODINE FORMULATIONS

#1479

20090304789

2009-12-10

NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS

#1480

20090304785

2009-12-10

Escalating dosing regimen for effecting weight loss and treating obesity

#1481

20090292016

2009-11-26

Stable Pharmaceutical Compositions Containing Pravastatin

#1482

20090285905

2009-11-19

Systems and processes for spray drying hydrophobic and hydrophilic components

#1483

20090285865

2009-11-19

Palatable, solid oral formulations for male chemical sterilization

#1484

20090281034

2009-11-12

Microencapsulation and sustained release of biologically active polypeptides

#1485

20090280186

2009-11-12

Process for producing spherical base granule comprising easily water-soluble drug

#1486

20090280181

2009-11-12

Device coated with glycogen particles comprising nucleic acid complexes

#1487

20090280159

2009-11-12

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#1488

20090275540

2009-11-05

Pre-compacted calcium-containing compositions

#1489

20090264600

2009-10-22

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

#1490

20090263475

2009-10-22

DEXLANSOPRAZOLE COMPOSITIONS

#1491

20090252805

2009-10-08

Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions

#1492

20090247575

2009-10-01

STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS

#1493

20090232897

2009-09-17

PHARMACEUTICAL COMPOSITIONS COMPRISING CONJUGATED ESTROGENS

#1494

20090232894

2009-09-17

Process for stabilizing an adjuvant containing vaccine composition

#1495

20090232885

2009-09-17

Drug delivery systems comprising weakly basic drugs and organic acids

#1496

20090226379

2009-09-10

Biphenyl compounds useful as muscarinic receptor antagonists

#1497

20090220613

2009-09-03

Controlled release delivery device comprising an organosol coat

#1498

20090215744

2009-08-27

Solid Formulations

#1499

20090214661

2009-08-27

Process for the production of beadlets

#1500

20090214645

2009-08-27

PHARMACEUTICAL COMPOSITIONS COMPRISING A PH-DEPENDENT DRUG, A PH MODIFIER AND A RETARDING AGENT